GlassScriptPhysician profile
Katelyn Shea
NPI 1053727099
$4,847.18
in general payments reported to CMS, 2019-2025
18 companies · $2,244 in 2025
The $2,244 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $555 · 2020: $228 · 2021: $125 · 2022: $507 · 2023: $151 · 2024: $1,038 · 2025: $2,244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,683 · Gift: $400 · Travel and Lodging: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,683.20 |
| Gift | $400.00 |
| Travel and Lodging | $348.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $820.60 | 2024-2025 | |
| Alcon Vision LLC | $640.35 | 2022-2025 | Precision7, Eysuvis, Dailies Total1 |
| Harrow Eye, LLC | $576.33 | 2024-2025 | Vevye |
| Visionary Optics LLC | $400.00 | 2025 | |
| Dompe US, INC. | $362.25 | 2021-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $317.02 | 2022-2024 | Infuse, Infuse Multifocal, Xiidra |
| Abbvie INC. | $298.04 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $277.02 | 2019-2020 | |
| Johnson & Johnson Vision Care, INC. | $270.62 | 2023-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $266.57 | 2019-2020 | |
| Coopervision INC. | $209.15 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Tarsus Pharmaceuticals, INC. | $109.63 | 2024-2025 | Xdemvy |
| Allergan, INC. | $100.43 | 2019 | |
| Glaukos Corporation | $77.16 | 2022 | |
| Oyster Point Pharma, INC. | $48.32 | 2024-2025 | Tyrvaya, Ryzumvi |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $35.99 | 2024-2025 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Eyevance Pharmaceuticals LLC | $18.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Shea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.